Skip to content

Observation and analysis of the clinical effect of using active ?-type copper-containing indomethacin intrauterine device after induced abortion

Observation and analysis of the clinical effect of using active ?-type copper-containing indomethacin intrauterine device after induced abortion

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053477
Enrollment
Unknown
Registered
2021-11-22
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immediate placement of intrauterine device after induced abortion

Interventions

Anshu ring group:No
Palace Ring Group:No
non-intrauterine device group:No

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Healthy women aged 18-40 who require early pregnancy termination; 2. Menstrual regularity, menstrual cycle 3-7/25-35 days; 3. Hemoglobin >= 9g/dL; 4. The pregnancy is less than or equal to 8 weeks; 5. The pregnancy process was normal, and there was no threatened abortion.

Exclusion criteria

Exclusion criteria: 1. Suffering from or suspected of reproductive tract infection; 2. Patients with heart disease, abnormal liver function, and blood system diseases; 3. The depth of the uterine cavity after negative pressure suction is more than 10cm; 4. Suspected incomplete miscarriage or intraoperative bleeding > 100ml after vacuum hysterectomy; 5. Patients with surgical complications such as perforation during surgery; 6. Obvious or multiple uterine fibroids; 7. Have endometriosis; 8. Breastfeeding women; 9. This pregnancy is a pregnancy with a device; 10. Within six months after cesarean section.

Design outcomes

Primary

MeasureTime frame
the safty of operation;

Secondary

MeasureTime frame
contraceptive effect;shedding rate;abnormal uterine bleeding;pain;Irregular menstruation;ncreased vaginal discharge;

Countries

China

Contacts

Public ContactTeng Yincheng

Shanghai Sixth People's Hospital

teng_yc@126.com+86 18930177643

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026